42502 Federal Register / Vol. 83, No. 163 / Wednesday, August 22, 2018 / Notices 

Please include your name, company 

name (if any), and ‘‘Information 

Collection 3090–0027, Contract 

Administration and Quality Assurance 

(GSA Forms 1678 and 308)’’, on your 

attached document. 

• Mail: General Services 

Administration, Regulatory Secretariat 

Division (MVCB), 1800 F Street NW, 

Washington, DC 20406. ATTN: Ms. 

Mandell/IC 3090–0027, Contract 

Administration and Quality Assurance 

(GSA Forms 1678 and 308). 

Instructions: Please submit comments 

only and cite Information Collection 

3090–0027, Contract Administration 

and Quality Assurance (GSA Forms 

1678 and 308), in all correspondence 

related to this collection. Comments 

received generally will be posted 

without change to regulations.gov, 

including any personal and/or business 

confidential information provided. To 

confirm receipt of your comment(s), 

please check regulations.gov, 

approximately two-to-three business 

days after submission to verify posting 

(except allow 30 days for posting of 

comments submitted by mail). 

SUPPLEMENTARY INFORMATION: 

A. Purpose 

Under certain contracts, because of 

reliance on contractor inspection in lieu 

of Government inspection, GSA’s 

Federal Acquisition Service requires 

documentation from its contractors to 

effectively monitor contractor 

performance and ensure that it will be 

able to take timely action should that 

performance be deficient. 

B. Annual Reporting Burden 

Response Time (Hours)—GSA Form 

1678: 1,875. 

Response Time (Hours)—GSA Form 

308: 200. 

Total Burden Hours: 2,075. 

C. Public Comments 

A 60-day notice published in the 

Federal Register at 83 FR 22064 on May 

11, 2018. No comments were received. 

Public comments are particularly 

invited on: Whether this collection of 

information is necessary and whether it 

will have practical utility; whether our 

estimate of the public burden of this 

collection of information is accurate and 

based on valid assumptions and 

methodology; and ways to enhance the 

quality, utility, and clarity of the 

information to be collected. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the General Services Administration, 

Regulatory Secretariat Division (MVCB), 

1800 F Street NW, Washington, DC 

20406, telephone 202–501–4755. Please 

cite OMB Control No. 3090–0027, 

Contract Administration, Quality 

Assurance (GSA Forms 1678 and 308), 

in all correspondence. 

Dated: August 17, 2018. 

Jeffrey A. Koses, 

Senior Procurement Executive, Office of 

Acquisition Policy, Office of Governmentwide Policy. 

[FR Doc. 2018–18120 Filed 8–21–18; 8:45 am] 

BILLING CODE 6820–61–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–18–1102; Docket No. CDC–2018– 

0049] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Information Collection for 

Tuberculosis Data from Panel 

Physicians, which collects TB data 

gathered during overseas immigration 

medical exams. 

DATES: CDC must receive written 

comments on or before October 22, 

2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2018– 

0049 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road, NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffery M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Information Collection for 

Tuberculosis Data from Panel 

Physicians—Revision—National Center 

for Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 


amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 163 / Wednesday, August 22, 2018 / Notices 42503 

Background and Brief Description 

The Centers for Disease Control and 

Prevention’s (CDC), National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Division of Global 

Migration and Quarantine (DGMQ), 

Immigrant, Refugee, and Migrant Health 

Branch (IRMH), requests approval for a 

revision of an existing information 

collection. This project pertains to 

collecting annual reports on certain 

tuberculosis data from U.S. panel 

physicians. 

The respondents are panel physicians. 

More than 760 panel physicians from 

336 panel sites perform overseas predeparture medical examinations in 

accordance with requirements, referred 

to as technical instructions, provided by 

DGMQs Quality Assessment Program 

(QAP). The role of QAP is to assist and 

guide panel physicians in the 

implementation of the Technical 

Instructions; evaluate the quality of the 

overseas medical examination for U.S.- 

bound immigrants and refugees; assess 

potential panel physician sites; and 

provide recommendations to the U.S. 

Department of State in matters of 

immigrant medical screening. 

To achieve DGMQ’s mission, the 

Immigrant, Refugee and Migrant Health 

branch (IRMH) works with domestic 

and international programs to improve 

the health of U.S.-bound immigrants 

and refugees to protect the U.S. public 

by preventing the importation of 

infectious disease. These goals are 

accomplished through IRMH’s oversight 

of medical exams required for all U.S.- 

bound immigrants and refugees who 

seek permanent residence in the U.S. 

IRMH is responsible for assisting and 

training the international panel 

physicians with the implementation of 

medical exam Technical Instructions 

(TI). Technical Instructions are detailed 

requirements and national policies 

regarding the medical screening and 

treatment of all U.S.-bound immigrants 

and refugees. 

Screening for tuberculosis (TB) is a 

particularly important component of the 

immigration medical exam and allows 

panel physicians to diagnose active TB 

disease prior to arrival in the United 

States. As part of the Technical 

Instructions requirements, panel 

physicians perform chest x-rays and 

laboratory tests that aid in the 

identification of tuberculosis infection 

(Class B1 applicants) and diagnosis of 

active tuberculosis disease (Class A, 

inadmissible applicants). CDC uses 

these classifications to report new 

immigrant and refugee arrivals with a 

higher risk of developing TB disease to 

U.S. state and local health departments 

for further follow-up. Some information 

that panel physicians collect as part of 

the medical exam is not reported on the 

standard Department of State forms (DSforms), thereby preventing CDC from 

evaluating TB trends in globally mobile 

populations and monitoring program 

effectiveness. 

Currently, CDC is requesting this data 

be sent by panel physicians once per 

year. The consequences of reducing this 

frequency would be the loss of 

monitoring program impact and TB 

burdens in mobile populations and 

immigrants and refugees coming to the 

United States on an annual basis. The 

total hours requested is 1,008. There is 

no cost to the respondents other than 

their time. 

Estimated annual burden is being 

reduced by 1,640 hours per year. The 

number of respondents is being reduced 

by 17. Reductions are due to revised 

estimates on burden time per response, 

and the removal of four variables from 

the data collection form and improved 

IT capacity at most panel sites. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

International panel physicians .......... TB Indicators Excel Spreadsheet .... 336 1 3 1,008 

Total ........................................... ........................................................... ........................ ........................ ........................ 1,008 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–18054 Filed 8–21–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–18–0338; Docket No. CDC–2018– 

0076] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS) 

ACTION: Notice with comment period 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing efforts to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on proposed work and/or 

continuing information collections, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a continuing information 

collection project titled Annual 

Submission of the Ingredients Added to, 

and the Quantity of Nicotine Contained 

in, Smokeless Tobacco Manufactured, 

Imported, or Packaged in the U.S. 

DATES: CDC must receive written 

comments on or before October 22, 

2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2018– 

0076 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 


amozie on DSK3GDR082PROD with NOTICES1